S100A8 and central nervous system cancer: Similarly, the study of Paul R. Gielen et al. also found glioma patients have increased S100A8/9 serum levels, at the same time, this study confirmed that S100A8/9 protein expression was statistical significantly increased in myeloid-derived suppressor cells of patients with glioma 67.